BioDefense as of early May 2010 being pushed in the UK by "Hang Seng Financial" trying to get £3 per share in a pre-IPO offer, the IPO being on AIM in a few months time, according to the story. Hey, story maybe right. Given all postings on this subject here, it would appear to me that usual...